Literature DB >> 17929165

Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.

Emad A Rakha1, Maysa E El-Sayed, Sindhu Menon, Andrew R Green, Andrew H S Lee, Ian O Ellis.   

Abstract

UNLABELLED: Invasive lobular carcinoma (ILC) comprises approximately 5-15% of breast cancers and appears to have a distinct biology. As it is less common than invasive ductal carcinoma, few studies of large size have addressed the value of assessment of histologic grade in ILC.
METHODS: This study is based on a large and well-characterised consecutive series of breast cancer (4,987 cases), from a single institution, with a long-term follow-up to assess the prognostic value of routine assessment of histologic grade in ILC. Histologic grade and other clinicopathological data were available in 517 pure ILC cases. A panel of biomarkers was also available for 215 cases.
RESULTS: The majority of ILC was of classical and mixed lobular variants (89%). Most ILC cases were moderately differentiated (grade 2) tumours (76%), while a small proportion of tumours were either grade 1 or 3 tumours (12% each). There were positive associations between histologic grade and other clinicopathological variables of poor prognosis such as larger size, positive lymph node, vascular invasion, oestrogen receptor and androgen receptor negativity and p53 positivity. Multivariate analyses showed that histologic grade is an independent predictor of shorter breast cancer specific survival and disease free interval.
CONCLUSION: Histologic grade of ILC, as assessed by the Nottingham grading system, provides a strong predictor of outcome in patients with invasive lobular carcinoma of the breast and should be provided routinely in pathology reports.

Entities:  

Mesh:

Year:  2007        PMID: 17929165     DOI: 10.1007/s10549-007-9768-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  38 in total

1.  Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Authors:  Otto Metzger-Filho; Arlindo R Ferreira; Rinath Jeselsohn; William T Barry; Deborah A Dillon; Jane E Brock; Ines Vaz-Luis; Melissa E Hughes; Eric P Winer; Nancy U Lin
Journal:  Oncologist       Date:  2018-12-05

Review 2.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

3.  Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

Authors:  Niamh Conlon; Dara S Ross; Jane Howard; Jeffrey P Catalano; Maura N Dickler; Lee K Tan
Journal:  Breast J       Date:  2015-08-14       Impact factor: 2.431

Review 4.  [Histological grading of breast cancer].

Authors:  M Christgen; F Länger; H Kreipe
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

5.  A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.

Authors:  Jing Li; Wenbin Jiang; Qirui Liang; Guanghao Liu; Yupeng Dai; Hailong Zheng; Jing Yang; Hao Cai; Guo Zheng
Journal:  BMC Genomics       Date:  2020-04-06       Impact factor: 3.969

6.  Leucoerythroblastosis and thrombocytopenia as clues to metastatic malignancy.

Authors:  E J Mahdi; A J Mahdi
Journal:  BMJ Case Rep       Date:  2014-01-31

7.  Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

Authors:  Min Yi; Elizabeth A Mittendorf; Janice N Cormier; Thomas A Buchholz; Karl Bilimoria; Aysegul A Sahin; Gabriel N Hortobagyi; Ana Maria Gonzalez-Angulo; Sheng Luo; Aman U Buzdar; Jaime R Crow; Henry M Kuerer; Kelly K Hunt
Journal:  J Clin Oncol       Date:  2011-11-14       Impact factor: 44.544

8.  Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.

Authors:  Hideo Takahashi; Masanori Oshi; Mariko Asaoka; Li Yan; Itaru Endo; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2020-05-20       Impact factor: 5.344

Review 9.  [Lobular neoplasms and invasive lobular breast cancer].

Authors:  H-P Sinn; B Helmchen; J Heil; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 10.  Histological and molecular types of breast cancer: is there a unifying taxonomy?

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.